AcelRx Pharma announces pricing of public offering of common stock

By Admin
AcelRx Pharmaceuticals, Inc announced the pricing of its previously underwritten public offering of 12,500,000 shares of its common stock, offered at a...

AcelRx Pharmaceuticals, Inc announced the pricing of its previously underwritten public offering of 12,500,000 shares of its common stock, offered at a price of $3.33 a share to the public.

The gross proceeds to AcelRx from this offering are expected to be about $4.138 million.  All the shares in the offering will be sold by AcelRx. The offering is expected to close on or about December 12. T

The company has granted the underwriters a 30-day option to buy up to an aggregate of 1,875, 000 additional shares of the common stock. 

Jefferies & Company, Inc and Cowen and Company, LLC are acting as joint book-running managers for the offering with Canaaccord Genuity, Inc acting as co-lead manager.

AcelRx Pharmaceuticals is a specialty pharmaceutical company focusing on development and commercialization of innovative therapies to treat acute and breakthrough pain.

The company was founded to solve the problems of post-operative intravenous patient-controlled analgesia. It has three additional product candidates in clinical development:

ARX-02 for treating of cancer through pain, ARX-03 to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician’s office and ARX-04, a non-invasive, fast-onset sublingual product to treat moderate-to-severe acute pain. 

Share

Featured Articles

GE Healthcare Tops FDA-Approved List of AI Medical Devices

GE HealthCare is investing in AI and ML to power tailor diagnoses, treatment, and ongoing monitoring and management for optimal patient outcomes

Digital Health Provider Spectrum.Life Seals Funding Round

Spectrum.Life, one of Europe’s fastest growing digital health providers, secures funding to grow team of clinicians and expand further into Europe

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

Medical Devices & Pharma

Tata Consultancy Report Shows AI in Healthcare on Rise

Technology & AI

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma